Cited by 268Amyotrophic Lateral Sclerosis ResearchNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis

Open access

Brettschneider, Johannes, Toledo, Jon B., Van Deerlin, Vivianna M., Elman, Lauren, McCluskey, Leo, Lee, Virginia M.-Y., Trojanowski, John Q.·2012·PLoS ONE

DOI 10.1371/journal.pone.0039216PMC PMC3375234

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND/AIMS: We evaluated clinicopathological correlates of upper motor neuron (UMN) damage in amyotrophic lateral sclerosis (ALS), and analyzed if the presence of the C9ORF72 repeat expansion was associated with alterations in microglial inflammatory activity. METHODS: Microglial pathology was assessed by IHC with 2 different antibodies (CD68, Iba1), myelin loss by Kluver-Barrera staining and myelin basic protein (MBP) IHC, and axonal loss by neurofilament protein (TA51) IHC, performed on 59 autopsy cases of ALS including 9 cases with C9ORF72 repeat expansion. RESULTS: Microglial pathology as depicted by CD68 and Iba1 was significantly more extensive in the corticospinal tract (CST) of ALS cases with a rapid progression of disease. Cases with C9ORF72 repeat expansion showed more extensive microglial pathology in the medulla and motor cortex which persisted after adjusting for disease duration in a logistic regression model. Higher scores on the clinical UMN scale correlated with increasing microglial pathology in the cervical CST. TDP-43 pathology was more extensive in the motor cortex of cases with rapid progression of disease. CONCLUSIONS: This study demonstrates that microglial pathology in the CST of ALS correlates with disease progression and is linked to severity of UMN deficits.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0039216

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Staging of CST degeneration in ALS. The figure illustrates the IHC staging used to grade the extent of microglial activation (CD68, Iba1) and axonal loss (MBP, KB, NF) in the CST of ALS patients. Images are taken from the lateral portion of the cervical CST. KB = Kluver-Barrera, MBP = myelin basic protein, NF = neurofilaments (TA51). Large images were taken with 4× objective, Scale bar is 1.0 mm. Small insert images were taken with 60× objective. Small insert image for CD68 stage “0” shows prominent neuronal nuclei, but no activated microglia.CC BY · PubMed Central

Figure 2 Microglial pathology, TDP-43, and neuro-axonal loss in the neuraxis of ALS. Bar plots show extent of microglial pathology as detected by staining for CD68 (a) and Iba1 (b) as well as TDP-43 pathology (c) and myelin loss as an indirect measure of axonal loss (d) in different regions of the neuraxis of ALS. For the spinal cord sections, the grey matter examined was the anterior horn and the white matter examined was the anterior and lateral portion of the CST. Whiskers in bar plot indicate 95% confidence interval of mean. CSC = cervical spinal cord, grey = grey matter, LSC = lumbar spinal cord, Med = medulla oblongata, motor = motor cortex (gyrus praecentralis), white = white matter.CC BY · PubMed Central

Figure 3 Microglial pathology and progression of disease. Bar plot shows microglial pathology as detected by staining for CD68 (a) and Iba1 (b) in ALS patients with a fast and a slow progression of disease. For the spinal cord sections, the grey matter examined was the anterior horn and the white matter examined was the anterior and lateral portion of the CST. Whiskers in bar plot indicate 95% confidence interval of mean. CSC = cervical spinal cord, grey = grey matter, LSC = lumbar spinal cord, Mot = motor cortex (gyrus praecentralis), Med = medulla oblongata, wh = white matter.CC BY · PubMed Central

Figure 4 Microglial pathology in ALS with/without C9ORF72 repeat expansion. Bar plot shows microglial pathology as detected by staining for CD68 (above) and Iba1 (below) in ALS patients with and without presence of a C9ORF72 repeat expansion. For the spinal cord sections, the grey matter examined was the anterior horn and the white matter examined was the anterior and lateral portion of the CST. Whiskers in bar plot indicate 95% confidence interval of mean. CSC = cervical spinal cord, gr = grey matter, LSC = lumbar spinal cord, Mot = motor cortex (gyrus praecentralis), Med = medulla oblongata, wh = white.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citation
Interrater Reliability of a Modified Ashworth Scale of Muscle Spasticity
Bohannon, R. W., & Smith, M. B. (1987) · Physical Therapy · doi:10.1093/ptj/67.2.206 · Cited by 5,461
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Amyotrophic lateral sclerosis
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase
Deng, H., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,479

Show all 68 references

Sorted by citations

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Inflammation and white matter degeneration persist for years after a single traumatic brain injury
Johnson, V. E., Stewart, J. E., Begbie, F. D., Trojanowski, J. Q., Smith, D. H., & Stewart, W. (2013) · Brain · doi:10.1093/brain/aws322 · Cited by 1,045
Self-citation
Microglia-mediated neuroinflammation in neurodegenerative diseases
Subhramanyam, C. S., Wang, C., Hu, Q., & Dheen, S. T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.004 · Cited by 894
Chronic neuropathologies of single and repetitive TBI: substrates of dementia?
Smith, D. H., Johnson, V. E., & Stewart, W. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.29 · Cited by 699
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
Beers, D. R., & Appel, S. H. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30394-6 · Cited by 396
Inflammation in ALS/FTD pathogenesis
McCauley, M. E., & Baloh, R. H. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1933-9 · Cited by 341
Neuroinflammation in frontotemporal dementia
Bright, F., Werry, E. L., Dobson-Stone, C., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kassiou, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0231-z · Cited by 280
TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord
Brettschneider, J., Arai, K., Tredici, K. D., Toledo, J. B., Robinson, J. L., Lee, E. B., Kuwabara, S., Shibuya, K., Irwin, D. J., Fang, L., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1299-6 · Cited by 279
Self-citation
TREM2 Variant p.R47H as a Risk Factor for Sporadic Amyotrophic Lateral Sclerosis
Cady, J., Koval, E. D., Benitez, B. A., Zaidman, C., Jockel-Balsarotti, J., Allred, P., Baloh, R. H., Ravits, J., Simpson, E., Appel, S. H., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.6237 · Cited by 262
TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss
Paolicelli, R. C., Jawaid, A., Henstridge, C. M., Valeri, A., Merlini, M., Robinson, J. L., Lee, E. B., Rose, J., Appel, S., Lee, V. M.-Y., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.05.037 · Cited by 239
Self-citation
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank
Toledo, J. B., Van Deerlin, V. M., Lee, E. B., Suh, E., Baek, Y., Robinson, J. L., Xie, S. X., McBride, J., Wood, E. M., Schuck, T., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.06.003 · Cited by 234
Self-citation
Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28
Zürcher, N. R., Loggia, M. L., Lawson, R., Chonde, D. B., Izquierdo-Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., Cudkowicz, M. E., et al. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.01.009 · Cited by 226
“In post mortem studies increased activated microglia are correlated with increased upper motor neuron symptoms and faster disease progression (Brettschneider et al., 2012).”
BackgroundInfluential
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 216
“Ramified microglia and macrophages with enlarged cytoplasm and short stout processes are present in the substantia nigra (400X magnification). d–f Amyotrophic lateral sclerosis (ALS) [38].”
Influential
How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia
van Blitterswijk, M., DeJesus‐Hernandez, M., & Rademakers, R. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a3efb · Cited by 211
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
Brites, D. M. T. O., & Vaz, A. R. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00117 · Cited by 213
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
“microglial activation that correlates with disease progression [438].”
Background
Chronic Traumatic Encephalopathy: The Neuropathological Legacy of Traumatic Brain Injury
Hay, J. R., Johnson, V. E., Smith, D. H., & Stewart, W. B., Jr. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044116 · Cited by 202
Microglia Disrupt Mesolimbic Reward Circuitry in Chronic Pain
Taylor, A. M. W., Castonguay, A., Taylor, A. J., Murphy, N. P., Ghogha, A., Cook, C. P., Xue, L., Olmstead, M. C., Koninck, Y. D., Evans, C. J., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4036-14.2015 · Cited by 196
Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases
Dupont, A.-C., Largeau, B., Santiago Ribeiro, M., Guilloteau, D., Tronel, C., & Arlicot, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040785 · Cited by 182
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum
Cruts, M., Gijselinck, I., Langenhove, T. V., van der Zee, J., & Broeckhoven, C. V. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.04.010 · Cited by 170
The microglial component of amyotrophic lateral sclerosis
Clarke, B. E., & Patani, R. (2020) · Brain · doi:10.1093/brain/awaa309 · Cited by 164
A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain
Umoh, M. E., Dammer, E. B., Dai, J., Duong, D. M., Lah, J. J., Levey, A. I., Gearing, M., Glass, J. D., & Seyfried, N. T. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201708202 · Cited by 157
Peripheral monocytes are functionally altered and invade the CNS in ALS patients
Zondler, L., Müller, K., Khalaji, S., Bliederhäuser, C., Ruf, W. P., Grozdanov, V., Thiemann, M., Fundel-Clemes, K., Freischmidt, A., Holzmann, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1548-y · Cited by 154
Non-neuronal cells in amyotrophic lateral sclerosis — from pathogenesis to biomarkers
Vahsen, B. F., Gray, E., Thompson, A. G., Ansorge, O., Anthony, D. C., Cowley, S. A., Talbot, K., & Turner, M. R. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00487-8 · Cited by 147
C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation
Lall, D., Lorenzini, I., Mota, T. A., Bell, S., Mahan, T. E., Ulrich, J. D., Davtyan, H., Rexach, J. E., Muhammad, A. K. M. G., Shelest, O., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.020 · Cited by 147
Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase
Oeckl, P., Weydt, P., Steinacker, P., Anderl-Straub, S., Nordin, F., Volk, A. E., Diehl-Schmid, J., Andersen, P. M., Kornhuber, J., Danek, A., et al. (2019) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-318868 · Cited by 139
Integrative transcriptomic analysis of the amyotrophic lateral sclerosis spinal cord implicates glial activation and suggests new risk genes
Humphrey, J., Venkatesh, S., Hasan, R., Herb, J. T., de Paiva Lopes, K., Küçükali, F., Byrska-Bishop, M., Evani, U. S., Narzisi, G., Fagegaltier, D., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01205-3 · Cited by 138
Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis
Thompson, A. G., Gray, E., Thézénas, M., Charles, P. D., Evetts, S., Hu, M. T., Talbot, K., Fischer, R., Kessler, B. M., & Turner, M. R. (2018) · Annals of Neurology · doi:10.1002/ana.25143 · Cited by 130
Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss
Schludi, M. H., Becker, L., Garrett, L., Gendron, T. F., Zhou, Q., Schreiber, F., Popper, B., Dimou, L., Strom, T. M., Winkelmann, J., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1711-0 · Cited by 137
Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis
Jin, M., Günther, R., Akgün, K., Hermann, A., & Ziemssen, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-62756-8 · Cited by 130
Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125
Disease-modifying therapies in amyotrophic lateral sclerosis
Chiò, A., Mazzini, L., & Mora, G. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107986 · Cited by 122
Neuroimmune regulation of GABAergic neurons within the ventral tegmental area during withdrawal from chronic morphine
Taylor, A. M. W., Castonguay, A., Ghogha, A., Vayssiere, P., Pradhan, A. A. A., Xue, L., Mehrabani, S., Wu, J., Levitt, P., Olmstead, M. C., et al. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.221 · Cited by 109
CSF chitinase proteins in amyotrophic lateral sclerosis
Thompson, A. G., Gray, E., Bampton, A., Raciborska, D., Talbot, K., & Turner, M. R. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-320442 · Cited by 112
ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression
Quek, H., Cuní‐López, C., Stewart, R., Colletti, T., Notaro, A., Sun, Y., Guo, C. C., Lupton, M. K., Nguyen, T. H., Oikari, L. E., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02421-1 · Cited by 108
Exposure of neonatal rats to alcohol has differential effects on neuroinflammation and neuronal survival in the cerebellum and hippocampus
Topper, L. A., Baculis, B. C., & Valenzuela, C. F. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0382-9 · Cited by 107
Traumatic Brain Injury as a Trigger of Neurodegeneration
Johnson, V. E., Stewart, W. B., Jr., Arena, J. D., & Smith, D. H. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_15 · Cited by 103
Non‐neuronal Cells in ALS: Role of Glial, Immune cells and Blood‐CNS Barriers
Puentes, F., Malaspina, A., van Noort, J. M., & Amor, S. (2016) · Brain Pathology · doi:10.1111/bpa.12352 · Cited by 100
Integrated magnetic resonance imaging and [11C]‐PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis
Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cernasov, P., Reynolds, B., Pijanowski, O., Chonde, D. B., Izquierdo‐Garcia, D., Mainero, C., Catana, C., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25251 · Cited by 99
Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?
Mähler, A., Mandel, S. A., Lorenz, M., Rüegg, U. T., Wanker, E. E., Boschmann, M., & Paul, F. (2013) · The EPMA Journal · doi:10.1186/1878-5085-4-5 · Cited by 99
Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective
Malaspina, A., Puentes, F., & Amor, S. (2014) · International Immunology · doi:10.1093/intimm/dxu099 · Cited by 92
Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis
Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cernasov, P., Chonde, D. B., Izquierdo‐Garcia, D., Yasek, J. E., Akeju, O., Catana, C., Rosen, B. R., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003427 · Cited by 90
White matter microglia heterogeneity in the CNS
Amor, S., McNamara, N. B., Gerrits, E., Marzin, M. C., Kooistra, S. M., Miron, V. E., & Nutma, E. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02389-x · Cited by 89
Senescent Microglia: The Key to the Ageing Brain?
Greenwood, E. K., & Brown, D. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094402 · Cited by 84
Emergence of Microglia Bearing Senescence Markers During Paralysis Progression in a Rat Model of Inherited ALS
Trias, E., Beilby, P. R., Kovacs, M., Ibarburu, S., Varela, V., Barreto-Núñez, R., Bradford, S. C., Beckman, J. S., & Barbeito, L. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00042 · Cited by 85
The clinical trial landscape in amyotrophic lateral sclerosis—Past, present, and future
Wobst, H. J., Mack, K. L., Brown, D. G., Brandon, N. J., & Shorter, J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21661 · Cited by 90
Plasma Inflammatory Cytokines Are Elevated in ALS
Tortelli, R., Zecca, C., Piccininni, M., Benmahamed, S., Dell’Abate, M. T., Barulli, M. R., Capozzo, R., Battista, P., & Logroscino, G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.552295 · Cited by 90
Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD
Diaper, D. C., Adachi, Y., Lazarou, L., Greenstein, M., Simoes, F. A., di Domenico, A., Solomon, D. A., Lowe, S. A., AlSubaie, R., Cheng, D., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt243 · Cited by 81
Examining the Relationship between Head Trauma and Neurodegenerative Disease: A Review of Epidemiology, Pathology and Neuroimaging Techniques
Sundman, M. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000137 · Cited by 83
NLRP3 Inflammasome Activation in a Transgenic Amyotrophic Lateral Sclerosis Model
Gugliandolo, A., Giacoppo, S., Bramanti, P., & Mazzon, E. (2017) · Inflammation · doi:10.1007/s10753-017-0667-5 · Cited by 79
C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9
Vahsen, B. F., Nalluru, S., Morgan, G. R., Farrimond, L. E., Carroll, E., Xu, Y., Cramb, K. M. L., Amein, B., Scaber, J., Katsikoudi, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41603-0 · Cited by 83
Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood
Mantovani, S., Gordon, R., Macmaw, J. K., Pfluger, C. M., Henderson, R. D., Noakes, P. G., McCombe, P., & Woodruff, T. M. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.09.005 · Cited by 78
Exploring the genetics and non-cell autonomous mechanisms underlying ALS/FTLD
Chen, H., Kankel, M. W., Su, S. C., Han, S., & Ofengeim, D. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0060-4 · Cited by 74
CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis
López-López, A., Gámez, J., Syriani, E., Morales, M., Salvadó, M., Rodríguez, M. J., Mahy, N., & Vidal-Taboada, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096528 · Cited by 74
RandomForest4Life: A Random Forest for predicting ALS disease progression
Hothorn, T., & Jung, H. H. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.893361 · Cited by 73
The role of inflammation in neurodegeneration: novel insights into the role of the immune system in C9orf72 HRE-mediated ALS/FTD
Masrori, P., Beckers, J., Gossye, H., & Damme, P. V. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00525-z · Cited by 80
What Does Imaging Reveal About the Pathology of Amyotrophic Lateral Sclerosis?
Turner, M. R., & Verstraete, E. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0569-6 · Cited by 71
Molecular Mechanisms of Neurodegeneration Related to C9orf72 Hexanucleotide Repeat Expansion
Leko, M. B., Župunski, V., Kirincich, J., Smilović, D., Hortobágyi, T., Hof, P. R., & Šimić, G. (2019) · Behavioural Neurology · doi:10.1155/2019/2909168 · Cited by 73
Pathology of callosal damage in ALS: An ex-vivo, 7 T diffusion tensor MRI study
Cárdenas, A. M., Sarlls, J. E., Kwan, J. Y., Bageac, D. V., Gala, Z. S., Danielian, L. E., Ray‐Chaudhury, A., Wang, H., Miller, K. L., Foxley, S., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.04.024 · Cited by 64
Sex Differences in Neurodegeneration: The Role of the Immune System in Humans
Lopez-Lee, C., Kodama, L., & Gan, L. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.01.002 · Cited by 69
Dissecting the pathobiology of altered MRI signal in amyotrophic lateral sclerosis: A post mortem whole brain sampling strategy for the integration of ultra-high-field MRI and quantitative neuropathology
Pallebage‐Gamarallage, M. M., Foxley, S., Menke, R., Huszár, I. N., Jenkinson, M., Tendler, B. C., Wang, C., Jbabdi, S., Turner, M. R., Miller, K. L., et al. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0416-1 · Cited by 64
Emerging Potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: An Update on Preclinical and Clinical Evidence
Angelopoulou, E., Pyrgelis, E.-S., & Piperi, C. (2022) · Molecules · doi:10.3390/molecules27238448 · Cited by 62
From nucleation to widespread propagation: A prion-like concept for ALS
Maniecka, Z., & Polymenidou, M. (2015) · Virus Research · doi:10.1016/j.virusres.2014.12.032 · Cited by 65
Immune mechanisms and shared immune targets in neurodegenerative diseases
Weiner, H. L. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01046-7 · Cited by 72
MCP1-CCR2 and neuroinflammation in the ALS motor cortex with TDP-43 pathology
Jara, J. H., Gautam, M., Koçak, N., Xie, E. F., Mao, Q., Bigio, E. H., & Özdi̇nler, P. H. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1589-y · Cited by 59
Voxel-based mapping of grey matter volume and glucose metabolism profiles in amyotrophic lateral sclerosis
Buhour, M.-S., Doidy, F., Mondou, A., Pèlerin, A., Carluer, L., Eustache, F., Viader, F., & Desgranges, B. (2017) · EJNMMI Research · doi:10.1186/s13550-017-0267-2 · Cited by 59
Integrated imaging of [11C]-PBR28 PET, MR diffusion and magnetic resonance spectroscopy 1H-MRS in amyotrophic lateral sclerosis
Ratai, E., Alshikho, M. J., Zürcher, N. R., Loggia, M. L., Cebulla, C. L., Cernasov, P., Reynolds, B., Fish, J., Seth, R., Babu, S., et al. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.08.007 · Cited by 62
Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis
Olesen, M. N., Wuolikainen, A., Nilsson, A. C., Wirenfeldt, M., Forsberg, K., Madsen, J. S., Lillevang, S. T., Brandslund, I., Andersen, P. M., & Asgari, N. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000697 · Cited by 59
Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis
Atassi, N., Xu, M., Triantafyllou, C., Keil, B. R., Lawson, R. J., Cernasov, P., Ratti, E., Long, C. J., Paganoni, S., Murphy, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177680 · Cited by 57
Impaired activation of ALS monocytes by exosomes
Zondler, L., Feiler, M. S., Freischmidt, A., Ruf, W. P., Ludolph, A. C., Danzer, K. M., & Weishaupt, J. H. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.89 · Cited by 57
11 C‐PK11195 PET–based molecular study of microglia activation in SOD1 amyotrophic lateral sclerosis
Tondo, G., Iaccarino, L., Cerami, C., Vanoli, G. E., Presotto, L., Masiello, V., Coliva, A., Salvi, F., Bartolomei, I., Mosca, L., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51112 · Cited by 56
“At the neuropathological level, microglia activation is increased in motor cortex, brainstem, and spinal cord, and the extent of activation seems to be associated with disease severity.(33) SOD1 mutations are considered as a potent trigger of microglia cells, and deleterious effects of microglial activation have been…”
Background
Cell-autonomous immune dysfunction driven by disrupted autophagy in C9orf72 -ALS iPSC-derived microglia contributes to neurodegeneration
Banerjee, P., Mehta, A. R., Nirujogi, R. S., Cooper, J. D., James, O. G., Nanda, J., Longden, J., Burr, K., McDade, K., Salzinger, A., et al. (2023) · Science Advances · doi:10.1126/sciadv.abq0651 · Cited by 57
Glia-specific autophagy dysfunction in ALS
Strohm, L., & Behrends, C. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.024 · Cited by 57
Evidence for an early innate immune response in the motor cortex of ALS
Jara, J. H., Genç, B., Stanford, M. J., Pytel, P., Roos, R. P., Weıntraub, S., Mesulam, M. M., Bigio, E. H., Miller, R. J., & Özdi̇nler, P. H. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0896-4 · Cited by 58
Microglia in Neurodegenerative Disorders
Tejera, D., & Heneka, M. T. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9658-2_5 · Cited by 54
Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K + currents in neurons
Vigil, F. A., Bozdemir, E., Bugay, V., Chun, S. H., Hobbs, M., Sanchez, I., Hastings, S. D., Veraza, R. J., Holstein, D. M., Sprague, S. M., et al. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19857818 · Cited by 51
The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis
Cox, L. M., Calcagno, N., Gauthier, C., Madore, C., Butovsky, O., & Weiner, H. L. (2022) · Microbiome · doi:10.1186/s40168-022-01232-z · Cited by 53
Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations
Marian, O. C., Teo, J. D., Lee, J. Y., Song, H., Kwok, J. B., Landin-Romero, R., Halliday, G., & Don, A. S. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01544-7 · Cited by 50
Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain
Swanson, M. E. V., Mrkela, M., Murray, H. C., Cao, M. C., Turner, C. P., Curtis, M. A., Faull, R. L. M., Walker, A. K., & Scotter, E. L. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01561-6 · Cited by 51
Microglia and Astrocytes in Amyotrophic Lateral Sclerosis: Disease-Associated States, Pathological Roles, and Therapeutic Potential
You, J., Youssef, M., Santos, J. R., Lee, J., & Park, J. (2023) · Biology · doi:10.3390/biology12101307 · Cited by 60
Crosstalk between Oxidative Stress and Inflammation Caused by Noise and Air Pollution—Implications for Neurodegenerative Diseases
Kuntić, M., Hahad, O., Münzel, T. F., & Daiber, A. (2024) · Antioxidants · doi:10.3390/antiox13030266 · Cited by 53
Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with 18F-DPA-714 and micro-PET/CT
Gargiulo, S., Anzilotti, S., Coda, A. R. D., Gramanzini, M., Greco, A., Panico, M., Vinciguerra, A., Zannetti, A., Vicidomini, C., Dollé, F., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3311-y · Cited by 48
Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model
Fellner, A., Barhum, Y., Angel, A., Perets, N., Steiner, I., Offen, D., & Lev, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081666 · Cited by 48
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis
Marini, C., Cistaro, A., Campi, C., Calvo, A., Caponnetto, C., Nobili, F. M., Fania, P., Beltrametti, M. C., Moglia, C., Novi, G., et al. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3440-3 · Cited by 47
Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts
Albrecht, D., Normandin, M. D., Shcherbinin, S., Wooten, D., Schwarz, A. J., Zürcher, N. R., Barth, V., Guehl, N. J., Akeju, O., Atassi, N., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178335 · Cited by 50
Astrocytes and Microglia as Potential Contributors to the Pathogenesis of C9orf72 Repeat Expansion-Associated FTLD and ALS
Rostalski, H., Leskelä, S., Huber, N., Katisko, K., Cajanus, A., Solje, E., Marttinen, M., Natunen, T., Remes, A. M., Hiltunen, M. O., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00486 · Cited by 47
Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis
Kjældgaard, A.-L., Pilely, K., Olsen, K. S., Pedersen, S. W., Lauritsen, A. Ø., Møller, K., & Garred, P. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.007 · Cited by 45
Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis
Cheong, I., Marjańska, M., Deelchand, D. K., Eberly, L. E., Walk, D., & Öz, G. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2248-2 · Cited by 48
Evidence for disrupted copper availability in human spinal cord supports CuII(atsm) as a treatment option for sporadic cases of ALS
Hilton, J. B. W., Kysenius, K., Liddell, J. R., Mercer, S. W., Paul, B. T., Beckman, J. S., McLean, C., White, A. R., Donnelly, P. S., Bush, A. I., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-55832-w · Cited by 45
Ophthalmic Manifestations of Amyotrophic Lateral Sclerosis (An American Ophthalmological Society Thesis).
Volpe, N. J., Simonett, J. M., Fawzi, A. A., & Siddique, T. (2015) · PubMed Central · Cited by 45
The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis
Pikatza‐Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz‐Gastesi, N., de Munaín, A. L., Gereñu, G., Gil-Bea, F. J., & Alonso‐Martín, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070671 · Cited by 48
Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C 9 ORF 72 hexanucleotide repeat expansion: a systematic neuropathological review
Schipper, L. J., Raaphorst, J., Aronica, E., Baas, F., de Haan, R. J., de Visser, M., & Troost, D. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12284 · Cited by 51
Positron Emission Tomography Molecular Imaging Biomarkers for Amyotrophic Lateral Sclerosis
Chew, S., & Atassi, N. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00135 · Cited by 43
The Genetics of C9orf72 ExpansionsPreprint
Gijselinck, I., Cruts, M., & Broeckhoven, C. V. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026757 · Cited by 43
RETRACTED: Effect of alpha-mangostin in the prevention of behavioural and neurochemical defects in methylmercury-induced neurotoxicity in experimental rats
Sahu, R., Mehan, S., Kumar, S., Prajapati, A., Alshammari, A., Alharbi, M., Assiri, M. A., & Narula, A. S. (2022) · Toxicology Reports · doi:10.1016/j.toxrep.2022.04.023 · Cited by 43
Retracted
Probiotics and microbial metabolites maintain barrier and neuromuscular functions and clean protein aggregation to delay disease progression in TDP43 mutation mice
Zhang, Y., Xia, Y., & Sun, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2363880 · Cited by 42
Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis
Crisafulli, S. G., Brajkovic, S., Mis, M. S. C., Parente, V., & Corti, S. P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0532-4 · Cited by 41
The Inflammatory Puzzle: Piecing together the Links between Neuroinflammation and Amyotrophic Lateral Sclerosis
He, D., Xu, Y. C., Liu, M., & Cui, L. (2023) · Aging and Disease · doi:10.14336/ad.2023.0519 · Cited by 43

Authors: Brettschneider, J., Toledo, J. B., Van Deerlin, V. M., Elman, L., McCluskey, L., Lee, V. M.-Y., & Trojanowski, J. Q.
Affiliations: Universität Ulm (DE)
University of Pennsylvania (US)
Corresponding author: Brettschneider, Johannes
ORCID: Toledo, Jon B.
Elman, Lauren
Lee, Virginia M.-Y.
Trojanowski, John Q.
Venue: PLoS ONE
Publisher: Public Library of Science (PLoS)
Published: 2012-06-14
Volume: 7
Issue: 6
Pages: e39216
ISSN: 1932-6203 (ISSN-L)
DOI: 10.1371/journal.pone.0039216
PMC: PMC3375234
OpenAlex: W1974485241
Cited by: 268
References: 68
Citations by year: 2026: 16 · 2025: 18 · 2024: 23 · 2023: 27 · 2022: 24 · 2021: 25 · 2020: 24 · 2019: 24 · 2018: 15 · 2017: 22 · 2016: 10 · 2015: 13 · 2014: 12 · 2013: 13 · 2012: 2
FWCI: 8.26
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (unspecified)
Locations: PLoS ONE (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
Funders: Deutsche Forschungsgemeinschaft (AG10124)
National Institutes of Health (AG 10 124, AG 17586)
National Institute on Aging (AG033101, AG-32953, P30AG010124, P01AG017586, AG17586, AG-10124, K08AG033101, P01AG032953)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: amyotrophic lateral sclerosis, microglial activation, upper motor neuron lesion, corticospinal tract, C9orf72 repeat expansion, disease progression, TDP-43 pathology, demyelination, axonal loss, neuroinflammation, motor cortex, medulla
MeSH terms: Aged, Amyotrophic Lateral Sclerosis, Axons, Base Sequence, Female, Humans, Male, Middle Aged, Motor Neurons, Cohort Studies, Polymerase Chain Reaction, Open Reading Frames, Microglia, DNA Primers, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks